Oxidative stress and vein graft failure: A focus on NADH oxidase, nitric oxide and eicosanoids

Current Opinion in Pharmacology

Volumn 12, Issue 2, 2012, Pages 160-165

  Weaver, Helen ^a   Shukla, Nilima ^a   Ellinsworth, David ^a   Jeremy, Jamie Y ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; APOCYNIN; ASCORBIC ACID; CYCLIC GMP; DIPHENYLIODONIUM SALT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSANOID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; PHOSPHODIESTERASE IV INHIBITOR; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; VITAMIN D;

AMINO TERMINAL SEQUENCE; ARTICLE; CARDIOVASCULAR DISEASE; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GRAFT FAILURE; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SAPHENOUS VEIN GRAFT; VASCULAR ENDOTHELIUM; VEIN GRAFT;

EID: 84861711662     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.01.005     Document Type: Review

References (39)

1. J.G. Motwani, and E.J. Topol Aortocoronary saphenous vein graft disease. Pathogenesis, predisposition and prevention Circulation 97 1998 916 931
2. J.Y. Jeremy, P. Gadsdon, N. Shukla, and G.D. Angelini On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents Biomaterials 28 2007 895 908
3. J.Y. Jeremy, C.L. Jackson, A.J. Bryan, and G.D. Angelini Eicosanoids, fatty acids and restenosis following coronary artery bypass graft surgery and balloon angioplasty Prostaglandins Leukot Essent Fatty Acids 54 1996 385 402
4. J.Y. Jeremy, D. Mehta, A.J. Bryan, and G.D. Angelini Platelets and saphenous vein graft failure Platelets 8 1997 295 309
5. J.Y. Jeremy, N. Shukla, S. Muzaffar, and G.D. Angelini Reactive oxygen species, vascular disease and cardiovascular surgery Curr Vasc Pharmacol 2 2004 229 236
6. J.Y. Jeremy, S. Muzaffar, C. Mill, and N. Shukla NADPH oxidase and atherosclerosis S. George, J. Johnson, Atherosclerosis 2010 Elsevier (pub) 242 252
7. N. West, T. Guzik, E. Black, and K. Channon Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase Arterioscler Thromb Vasc Biol 21 2001 189 194
8. E.J. West, T.J. Guzik, and E. Black Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia Arterioscler Thromb Vasc Biol 21 2000 189 194
9. N.E. West, H. Qian, and T.J. Guzik Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production Circulation 104 2001 1526 1532
10. T.J. Guzik, S. Mussa, and D. Gastaldi Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase Circulation 105 2002 1656 1662
11. J.Y. Jeremy, A.P. Yim, S. Wan, and G.D. Angelini Oxidative stress, nitric oxide and vascular disease Cardiovasc Surg 17 2002 324 327
12. D.I. Brown, and K.K. Griendling Nox proteins in signal transduction Free Rad Biol Med 8 2008 1239 1253
13. K. Bedard, and K.H. Krause The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol Rev 87 2007 245 313
14. B.M. Babior NADPH oxidase Curr Opin Immunol 16 2004 42 47
15. S. Muzaffar, N. Shukla, G.D. Angelini, and J.Y. Jeremy Superoxide auto-augments superoxide formation in isolated porcine pulmonary artery endothelial cells through upregulation of NADPH oxidase expression: inhibition with iloprost Eur J Pharmacol 538 2006 108 114
16. S. Muzaffar, N. Shukla, M. Bond, G.D. Angelini, and J.Y. Jeremy Superoxide from NADPH oxidase upregulates type 5 phosphodiesterase in human vascular smooth muscle cells: inhibition with iloprost and NONOate Br J Pharmacol 155 2008 847 856
17. S. Muzaffar, J.Y. Jeremy, G.D. Angelini, K. Stuart-Smith, and N. Shukla The role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries Thorax 58 2003 598 604
18. S. Muzaffar, N. Shukla, G.D. Angelini, and J.Y Jeremy Nitroaspirins and SIN-1, but not aspirin, inhibit the expression of endotoxin- and cytokine-induced NADPH oxidase in vascular smooth muscle cells from pig pulmonary arteries Circulation 110 2004 1140 1147
19. α2 in cultured porcine pulmonary artery vascular smooth muscle cells Br J Pharmacol 141 2004 488 496
20. S. Muzaffar, N. Shukla, M. Bond, G. Sala Newby, A.C. Newby, G.D. Angelini, and J.Y. Jeremy Acute inhibition of superoxide formation and rac-1 activation in human vascular smooth muscle cells by NONOate and iloprost Prostaglandins Leukot Essent Fatty Acids 78 2008 247 255
21. S. Muzaffar, N. Shukla, G.D. Angelini, and J.Y. Jeremy Roflumilast N-oxide inhibits NADPH oxidase expression and activity in human pulmonary artery smooth muscle cells Proc Br Pharm Soc 61 2009 027P
22. 2 synthase in human vascular smooth muscle cells: inhibition with iloprost Eur J Pharmacol 658 2011 187 192
23. phox and endothelial nitric oxide synthase which promotes peroxynitrite formation in the pig pulmonary artery Thorax 60 2005 305 313
24. J.Y. Jeremy, D. Rowe, A.M. Emsley, and A.C. Newby Nitric oxide and vascular smooth muscle cell proliferation Cardiovasc Res 43 1999 658 665
25. G. Kojda, and D. Harrison Interaction between NO and reactive oxygen species: pathological importance in atherosclerosis, hypertension, diabetes and heart failure Cardiovasc Res 43 1999 562 571
26. J.Y. Jeremy, S. Birkett, A.J. Bryan, and G.D. Angelini Cyclic nucleotide synthesis by freshly isolated and surgically prepared human saphenous vein before and after 14 days culture Eur J Vasc Endovasc Surg 13 1997 72 78
27. J.Y. Jeremy, M. Dashwood, M. Timm, M. Izzat, and G.D. Angelini Nitric oxide synthase and cyclic nucleotide synthesis by porcine venous-arterial grafts Ann Thorac Surg 63 1997 470 476
28. phox expression in porcine pulmonary artery endothelial cells Br J Pharmacol 141 2005 488 496
29. S. Muzaffar, N. Shukla, G.D. Angelini, and J.Y. Jeremy NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells J Cell Physiol. 227 2012 1941 1950
30. T.J. Guzik, and D.G. Harrison Vascular NADPH oxidases as drug targets for novel antioxidant strategies Drug Discov Today 11 2006 524 533
31. F. Jiang, G.R. Drummond, and G.J. Dusting Suppression of oxidative stress in the endothelium and vascular wall Endothelium 111 2004 79 88
32. E. Aldieri, C. Rignati, and M. Polimeni Classical inhibitors of NOX NAD(P)H oxidases are not specific Curr Drug Metab 9 2008 686 696
33. J. Bloor, N. Shukla, F.C.T. Smith, G.D. Angelini, and J.Y. Jeremy Folic acid administration reduces neointimal thickening, augments neo vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from diabetic pigs Diabetologia 53 2010 980 988
34. N. Shukla, N.S. Greaves, G.D. Angelini, and J.Y. Jeremy Folic acid reduces intravascular oxidative stress in diabetic rabbits Metabolism 57 2008 774 781
35. S. Wan, A. Yim, N. Shukla, J.L. Johnson, G.D. Angelini, and J.Y. Jeremy Nitric oxide donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein into carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine J Thorac Cardiovasc Surg 133 2007 494 500
36. S. Wan, A. Yim, N. Shukla, J.L. Johnson, G.D. Angelini, and J.Y. Jeremy Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein grafts J Thorac Cardiovasc Surg 133 2007 494 500
37. J.Y. Jeremy, A. Kaura, J.L. Sablayrolles, and G.D. Angelini Saphenous vein graft attrition J. Escaned, P.W. Serruys, Coronary Stenosis: Imaging, Structure and Physiology 2010 PCR Publishing (pub) 458 473
38. phox expression in arterial endothelial cells: role of protein kinases A and G Br J Pharmacol 155 2008 984 994
39. S. Muzaffar, J.Y. Jeremy, A. Sparatore, P. Del Soldato, G.D. Angelini, and N. Shukla Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac(1) activity in human vascular smooth muscle cells J Vasc Res 45 2008 521 528